{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T10:56:18Z","timestamp":1740135378705,"version":"3.37.3"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,10,29]],"date-time":"2022-10-29T00:00:00Z","timestamp":1667001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,10,29]],"date-time":"2022-10-29T00:00:00Z","timestamp":1667001600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Intramural Research Grant","award":["(2-5)"],"award-info":[{"award-number":["(2-5)"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Neuroleptic malignant syndrome (NMS) is a rare and occasionally fatal undesirable reaction to dopamine antagonists, and its phenotype is diverse owing to causative drugs. Classically, elevation of serum creatine kinase is described in NMS. Some reports have described muscular pathological findings; however, muscle magnetic resonance imaging (MRI) has not been reported previously.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>A 63-year-old woman with a history of schizophrenia presented to our hospital with a high fever, excessive sweating, muscle weakness, and elevated serum creatine kinase levels. Muscle MRI revealed T2 high-intensity lesions in several muscles with gadolinium enhancement, and the pathology of the muscle biopsy showed a very mild presence of muscle fiber necrosis and regeneration with type 2c fibers without inflammation. Her symptoms resolved by treatment with levodopa\/carbidopa, dantrolene. Finally, the patient was diagnosed with NMS.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>This is the first report of muscle MRI abnormalities in a patient with NMS. Muscle MRI abnormalities in NMS may be associated with non-inflammatory myopathic changes. The cause of creatine kinase elevation cannot be explained by abnormal strong muscle contraction nor inflammation.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12883-022-02937-2","type":"journal-article","created":{"date-parts":[[2022,10,29]],"date-time":"2022-10-29T05:02:46Z","timestamp":1667019766000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Muscle magnetic resonance imaging abnormality in neuroleptic malignant syndrome: a case report"],"prefix":"10.1186","volume":"22","author":[{"given":"Yuki","family":"Kakinuma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8946-9475","authenticated-orcid":false,"given":"Ryota","family":"Amano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Ishida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ichizo","family":"Nishino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsumi","family":"Taki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,10,29]]},"reference":[{"issue":"3","key":"2937_CR1","first-page":"79","volume":"41","author":"SN Caroff","year":"1980","unstructured":"Caroff SN. The neuroleptic malignant syndrome. J Clin Psychiatry. 1980;41(3):79\u201383.","journal-title":"J Clin Psychiatry"},{"issue":"6","key":"2937_CR2","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1176\/ajp.2007.164.6.870","volume":"164","author":"JR Strawn","year":"2007","unstructured":"Strawn JR, Keck PE Jr, Caroff SN. Neuroleptic malignant syndrome. Am J Psychiatry. 2007;164(6):870\u20136. https:\/\/doi.org\/10.1176\/ajp.2007.164.6.870.","journal-title":"Am J Psychiatry"},{"issue":"9","key":"2937_CR3","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.4088\/JCP.10m06438","volume":"72","author":"RJ Gurrera","year":"2011","unstructured":"Gurrera RJ, Caroff SN, Cohen A, Carroll BT, DeRoos F, Francis A, et al. An international consensus study of neuroleptic malignant syndrome diagnostic criteria using the Delphi method. J Clin Psychiatry. 2011;72(9):1222\u20138. https:\/\/doi.org\/10.4088\/JCP.10m06438.","journal-title":"J Clin Psychiatry"},{"issue":"6","key":"2937_CR4","doi-asserted-by":"publisher","first-page":"e15818","DOI":"10.7759\/cureus.15818","volume":"13","author":"S Desai","year":"2021","unstructured":"Desai S, Hirachan T, Toma A, Gerolemou A. Malignant Catatonia Versus Neuroleptic Malignant Syndrome. Cureus. 2021;13(6):e15818. https:\/\/doi.org\/10.7759\/cureus.15818.","journal-title":"Cureus"},{"issue":"1","key":"2937_CR5","first-page":"84","volume":"49","author":"R van Rensburg","year":"2019","unstructured":"van Rensburg R, Decloedt EH. An Approach to the Pharmacotherapy of Neuroleptic Malignant Syndrome. Psychopharmacol Bull. 2019;49(1):84\u201391.","journal-title":"Psychopharmacol Bull"},{"issue":"2","key":"2937_CR6","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1097\/00002826-198704000-00010","volume":"10","author":"M Harris","year":"1987","unstructured":"Harris M, Nora L, Tanner CM. Neuroleptic malignant syndrome responsive to carbidopa\/levodopa: support for a dopaminergic pathogenesis. Clin Neuropharmacol. 1987;10(2):186\u20139. https:\/\/doi.org\/10.1097\/00002826-198704000-00010.","journal-title":"Clin Neuropharmacol"},{"issue":"2","key":"2937_CR7","doi-asserted-by":"publisher","first-page":"130","DOI":"10.2165\/00003495-198632020-00003","volume":"32","author":"A Ward","year":"1986","unstructured":"Ward A, Chaffman MO, Sorkin EM. Dantrolene A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in malignant hyperthermia, the neuroleptic malignant syndrome and an update of its use in muscle spasticity. Drugs. 1986;32(2):130\u201368. https:\/\/doi.org\/10.2165\/00003495-198632020-00003.","journal-title":"Drugs"},{"issue":"3","key":"2937_CR8","doi-asserted-by":"publisher","first-page":"e12954","DOI":"10.1111\/bpa.12954","volume":"31","author":"S Malartre","year":"2021","unstructured":"Malartre S, Bachasson D, Mercy G, Sarkis E, Anquetil C, Benveniste O, et al. MRI and muscle imaging for idiopathic inflammatory myopathies. Brain Pathol. 2021;31(3):e12954. https:\/\/doi.org\/10.1111\/bpa.12954.","journal-title":"Brain Pathol"},{"issue":"3","key":"2937_CR9","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1136\/jnnp.53.3.271","volume":"53","author":"A Bakheit","year":"1990","unstructured":"Bakheit A, Behan WM. Pathology of neuroleptic malignant syndrome. J Neurol Neurosurg Psychiatry. 1990;53(3):271. https:\/\/doi.org\/10.1136\/jnnp.53.3.271.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"2","key":"2937_CR10","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1007\/bf00718024","volume":"235","author":"DT Martin","year":"1987","unstructured":"Martin DT, Swash M. Muscle pathology in the neuroleptic malignant syndrome. J Neurol. 1987;235(2):120\u20131. https:\/\/doi.org\/10.1007\/bf00718024.","journal-title":"J Neurol"},{"issue":"2","key":"2937_CR11","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/0002-9343(84)90716-2","volume":"77","author":"GP Downey","year":"1984","unstructured":"Downey GP, Rosenberg M, Caroff S, Beck S, Rosenberg H, Gerber JC, et al. Neuroleptic malignant syndrome Patient with unique clinical and physiologic features. Am J Med. 1984;77(2):338\u201340. https:\/\/doi.org\/10.1016\/0002-9343(84)90716-2.","journal-title":"Am J Med"},{"issue":"3","key":"2937_CR12","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1136\/jcp.53.3.223","volume":"53","author":"WM Behan","year":"2000","unstructured":"Behan WM, Madigan M, Clark BJ, Goldberg J, McLellan DR. Muscle changes in the neuroleptic malignant syndrome. J Clin Pathol. 2000;53(3):223\u20137. https:\/\/doi.org\/10.1136\/jcp.53.3.223.","journal-title":"J Clin Pathol"},{"issue":"1","key":"2937_CR13","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s40268-014-0078-0","volume":"15","author":"M Belvederi Murri","year":"2015","unstructured":"Belvederi Murri M, Guaglianone A, Bugliani M, Calcagno P, Respino M, Serafini G, et al. Second-generation antipsychotics and neuroleptic malignant syndrome: systematic review and case report analysis. Drugs R D. 2015;15(1):45\u201362. https:\/\/doi.org\/10.1007\/s40268-014-0078-0.","journal-title":"Drugs R D"},{"key":"2937_CR14","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.ajp.2019.04.007","volume":"43","author":"F Vellekkatt","year":"2019","unstructured":"Vellekkatt F, Kuppili PP, Bharadwaj B, Menon V. Atypical neuroleptic malignant syndrome \u2013 A case report. Asian J Psychiatr. 2019;43:7\u20138. https:\/\/doi.org\/10.1016\/j.ajp.2019.04.007.","journal-title":"Asian J Psychiatr"},{"issue":"1","key":"2937_CR15","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1192\/bjp.bp.111.105189","volume":"201","author":"JN Trollor","year":"2012","unstructured":"Trollor JN, Chen X, Chitty K, Sachdev PS. Comparison of neuroleptic malignant syndrome induced by first- and second-generation antipsychotics. Br J Psychiatry. 2012;201(1):52\u20136. https:\/\/doi.org\/10.1192\/bjp.bp.111.105189.","journal-title":"Br J Psychiatry"},{"issue":"1","key":"2937_CR16","doi-asserted-by":"publisher","first-page":"17r02185","DOI":"10.4088\/PCC.17r02185","volume":"20","author":"MR Ware","year":"2018","unstructured":"Ware MR, Feller DB, Hall KL. Neuroleptic Malignant Syndrome: Diagnosis and Management. Prim Care Companion CNS Disord. 2018;20(1):17r02185. https:\/\/doi.org\/10.4088\/PCC.17r02185.","journal-title":"Prim Care Companion CNS Disord"},{"issue":"4","key":"2937_CR17","doi-asserted-by":"publisher","first-page":"464","DOI":"10.4088\/jcp.v65n0403","volume":"65","author":"J Ananth","year":"2004","unstructured":"Ananth J, Parameswaran S, Gunatilake S, Burgoyne K, Sidhom T. Neuroleptic malignant syndrome and atypical antipsychotic drugs. J Clin Psychiatry. 2004;65(4):464\u201370. https:\/\/doi.org\/10.4088\/jcp.v65n0403.","journal-title":"J Clin Psychiatry"},{"issue":"11","key":"2937_CR18","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1177\/1060028016657553","volume":"50","author":"DJ Pileggi","year":"2016","unstructured":"Pileggi DJ, Cook AM. Neuroleptic Malignant Syndrome. Ann Pharmacother. 2016;50(11):973\u201381. https:\/\/doi.org\/10.1177\/1060028016657553.","journal-title":"Ann Pharmacother"},{"issue":"9","key":"2937_CR19","doi-asserted-by":"publisher","first-page":"669","DOI":"10.5692\/clinicalneurol.51.669","volume":"51","author":"I Nishino","year":"2011","unstructured":"Nishino I. ABC in muscle pathology. Rinsho Shinkeigaku. 2011;51(9):669\u201376. https:\/\/doi.org\/10.5692\/clinicalneurol.51.669.","journal-title":"Rinsho Shinkeigaku"},{"issue":"1","key":"2937_CR20","doi-asserted-by":"publisher","first-page":"7246","DOI":"10.1038\/s41598-020-64287-8","volume":"10","author":"JR Dahlqvist","year":"2020","unstructured":"Dahlqvist JR, Salim R, Thomsen C, Vissing J. A quantitative method to assess muscle edema using short TI inversion recovery MRI. Sci Rep. 2020;10(1):7246. https:\/\/doi.org\/10.1038\/s41598-020-64287-8.","journal-title":"Sci Rep"},{"issue":"8","key":"2937_CR21","doi-asserted-by":"publisher","first-page":"650","DOI":"10.5692\/clinicalneurol.53.650","volume":"53","author":"N Matsuda","year":"2013","unstructured":"Matsuda N, Kobayashi S, Otani K, Hasegawa O, Ugawa Y. Skeletal muscle MRI in a patient with neuralgic amyotrophy. Rinsho Shinkeigaku. 2013;53(8):650\u20133. https:\/\/doi.org\/10.5692\/clinicalneurol.53.650.","journal-title":"Rinsho Shinkeigaku"},{"issue":"3","key":"2937_CR22","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1097\/01.rct.0000250115.10457.e9","volume":"31","author":"CH Lu","year":"2007","unstructured":"Lu CH, Tsang YM, Yu CW, Wu MZ, Hsu CY, Shih TT. Rhabdomyolysis: magnetic resonance imaging and computed tomography findings. J Comput Assist Tomogr. 2007;31(3):368\u201374. https:\/\/doi.org\/10.1097\/01.rct.0000250115.10457.e9.","journal-title":"J Comput Assist Tomogr"},{"issue":"1","key":"2937_CR23","doi-asserted-by":"publisher","first-page":"11","DOI":"10.5847\/wjem.j.issn.1920-8642.2012.01.002","volume":"3","author":"MH Zhang","year":"2012","unstructured":"Zhang MH. Rhabdomyolosis and its pathogenesis. World J Emerg Med. 2012;3(1):11\u20135. https:\/\/doi.org\/10.5847\/wjem.j.issn.1920-8642.2012.01.002.","journal-title":"World J Emerg Med"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-022-02937-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12883-022-02937-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-022-02937-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,29]],"date-time":"2022-10-29T05:03:13Z","timestamp":1667019793000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-022-02937-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,29]]},"references-count":23,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["2937"],"URL":"https:\/\/doi.org\/10.1186\/s12883-022-02937-2","relation":{},"ISSN":["1471-2377"],"issn-type":[{"type":"electronic","value":"1471-2377"}],"subject":[],"published":{"date-parts":[[2022,10,29]]},"assertion":[{"value":"27 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Studies involving human participants are reviewed and approved by Fujiyoshida Municipal Medical Center. The patient provided written informed consent to participate in this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written consent was obtained from the patient for publication of this report and accompanying images.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"396"}}